Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DICLOXACILLIN Cause Tubulointerstitial nephritis? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Tubulointerstitial nephritis have been filed in association with DICLOXACILLIN (DICLOXACILLIN SODIUM). This represents 12.3% of all adverse event reports for DICLOXACILLIN.

38
Reports of Tubulointerstitial nephritis with DICLOXACILLIN
12.3%
of all DICLOXACILLIN reports
1
Deaths
33
Hospitalizations

How Dangerous Is Tubulointerstitial nephritis From DICLOXACILLIN?

Of the 38 reports, 1 (2.6%) resulted in death, 33 (86.8%) required hospitalization, and 2 (5.3%) were considered life-threatening.

Is Tubulointerstitial nephritis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DICLOXACILLIN. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does DICLOXACILLIN Cause?

Pyrexia (36) Acute kidney injury (34) Drug hypersensitivity (33) Rash (27) Abdominal discomfort (26) Diarrhoea (23) Drug ineffective (22) Pruritus (22) Erythema (18) Blood creatinine increased (15)

What Other Drugs Cause Tubulointerstitial nephritis?

OMEPRAZOLE (4,809) ESOMEPRAZOLE (4,024) LANSOPRAZOLE (3,860) PANTOPRAZOLE (3,590) DEXLANSOPRAZOLE (2,177) RABEPRAZOLE (1,125) PEMBROLIZUMAB (860) IBUPROFEN (844) VANCOMYCIN (523) TACROLIMUS (486)

Which DICLOXACILLIN Alternatives Have Lower Tubulointerstitial nephritis Risk?

DICLOXACILLIN vs DICYCLOMINE DICLOXACILLIN vs DIDANOSINE DICLOXACILLIN vs DIENOGEST DICLOXACILLIN vs DIENOGEST\ESTRADIOL DICLOXACILLIN vs DIENOGEST\ETHINYL ESTRADIOL

Related Pages

DICLOXACILLIN Full Profile All Tubulointerstitial nephritis Reports All Drugs Causing Tubulointerstitial nephritis DICLOXACILLIN Demographics